Stocks making the biggest moves midday: Wynn Resorts, Rocket Lab USA, Cassava Sciences and more

[ad_1] Check out the companies making headlines in midday trading: Bristol-Myers Squibb — The drug maker…

10 things to watch in the stock market Friday including a bullish call on Best Buy

[ad_1] 10 things to watch Friday, Sept. 27 1. The S & P 500 was looking…

FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades

[ad_1] Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on…

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

[ad_1] Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer…

What’s next for the Biden administration’s Medicare drug price negotiations

[ad_1] U.S. President Joe Biden and Vice President Kamala Harris walk out together, at an event…

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

[ad_1] President Joe Biden speaks during an event at the National Institutes of Health in Bethesda,…

Stocks making the biggest moves before the bell: McDonald’s, Tesla, Stellantis and more

[ad_1] Check out the companies making headlines in premarket trading: McDonald’s — Shares were down slightly…

Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs 

[ad_1] The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on…

Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter —…

Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers

[ad_1] US President Joe Biden speaks during an event at the National Institutes of Health (NIH)…

This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A

[ad_1] Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class…

A corner of the cancer therapy market is heating up—Here are the names investors need to know

[ad_1] There’s been a lot of attention lately on a corner of the oncology market called…

Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss

[ad_1] The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on…